Results from the check details current study suggest that CMR was

unable to improve perceptions of pleasure and activation. In contrast, Rollo et al. [7] reported that CMR increased feelings of pleasure during the first five minutes of a 30 min running procedure. Discrepancies between these findings are likely to be due to the different demands of the exercise H 89 molecular weight protocols. Specifically, the aim of Rollo and colleagues protocol was to sustain a pace, which denoted a rating of 15 on the RPE scale [7], while the current study required participants to perform the sprints of the LIST and RSA tests. Perhaps, as optimal performance in the current study required participants to perform maximally during the sprints, the overriding motivation to perform well may have negated any small changes in the feelings of pleasure-displeasure and activation induced by the presence of CHO in the oral cavity www.selleckchem.com/products/nsc-23766.html [30]. In addition, any central changes caused by CMR may be evident for multiple sprint activity

of 60 min or greater in duration. Though further research is required to confirm this notion, it may be supported by Backhouse et al. [18] who reported that CHO ingestion only improves perceived activation between 60 and 90 min of the LIST protocol. Hypothetically, Carter et al. [5] suggest that CMR results in a cephalic rise in insulin and blood glucose, which improves performance by facilitating glucose uptake into the muscle. Contrary to this postulation, our current study indicates that CMR exerts no effect on blood glucose during multiple sprint exercise. This agrees with previous literature reporting that CMR has no influence on blood glucose concentrations during endurance exercise [31]. Although we did not measure peripheral changes in metabolism in our current study, our results support to the notion that CMR exerts little or no metabolic changes.

Despite the Masitinib (AB1010) relatively small sample size of our study, we are confident in our findings. A major strength of our current study is that it represents a fairly “real world” testing scenario synonymous with sport as the LIST correlates well with soccer and hockey performance [16, 32]. Overall, we used a randomized, crossover treatment assignment to CMR and placebo conditions, whereby participants in our study served as their own controls. The results of our RSA test coefficient of variations for fastest and mean sprint time (1.2%) were similar to other studies using RSA tests [33] and LIST [16]. The trivial effect sizes between trials questions whether there is any ergogenic influence of CMR on multiple sprint performance. We also observed very low coefficients of variation between testing each testing condition (all, < 2.0%). Thus, our study was additionally robust owing to the small variance that we observed between testing conditions, which ultimately attest to the reliability of our study protocol.